TR200401511T4 - Nöropatik ağrı ve baş ağrısı nöbetleri ve migren tipi baş ağrısı ile ilişkili ağrının önlenmesi veya tedavi edilmesinde kullanılan karbamat bileşikleri. - Google Patents

Nöropatik ağrı ve baş ağrısı nöbetleri ve migren tipi baş ağrısı ile ilişkili ağrının önlenmesi veya tedavi edilmesinde kullanılan karbamat bileşikleri.

Info

Publication number
TR200401511T4
TR200401511T4 TR2004/01511T TR200401511T TR200401511T4 TR 200401511 T4 TR200401511 T4 TR 200401511T4 TR 2004/01511 T TR2004/01511 T TR 2004/01511T TR 200401511 T TR200401511 T TR 200401511T TR 200401511 T4 TR200401511 T4 TR 200401511T4
Authority
TR
Turkey
Prior art keywords
headache
prevent
compounds used
attacks
phenyl
Prior art date
Application number
TR2004/01511T
Other languages
English (en)
Inventor
E. Codd Ellen
P. Shank Richard
E. Rogers Katherine
R. Plata-Salaman Carlos
Zhao Boyu
Original Assignee
Ortho-Mcneil Pharmaceutical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22820176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200401511(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho-Mcneil Pharmaceutical, Inc. filed Critical Ortho-Mcneil Pharmaceutical, Inc.
Publication of TR200401511T4 publication Critical patent/TR200401511T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

(FORMÜL (I)); Bu bulus, nöropatik agri ve bas agrisi nöbetleri ve migren bas agrisi kaynakli agrinin önlenmesi veya tedavi edilmesinde ihtiyaci olan bir hastaya büyük ölçüde diger enantiomerler veya bir formül (I) enantiomerinin çogunlukta oldugu bir enantiometrik karisim içermeyen Formül (I) enantiomerinin tedavi edici olarak etkili bir miktarinin uygulanmasini içeren bir yönteme yöneliktir. Formül (I) burada fenil X konumunda flor, klor, brom ve iyottan olusan gruptan bagimsiz olarak seçilen bir ila bes halojen atomuyla sübstitüe edilir; ve R1 ve R2 hidrojen ve C1-C4 alkilden olusan gruptan bagimsiz olarak seçilir; burada C1-C4 alkil opsiyonel olarak fenil ile (burada fenil opsiyonel olarak hidrojen, halojen, C1-C4 alkil, C1-C4 alkoksi, amino, nitro ve siyanodan olusan gruptan bagimsiz olarak seçilen sübstitüanlar ile sübstitüe edilir) sübstitüe edilir.
TR2004/01511T 2000-07-21 2001-07-16 Nöropatik ağrı ve baş ağrısı nöbetleri ve migren tipi baş ağrısı ile ilişkili ağrının önlenmesi veya tedavi edilmesinde kullanılan karbamat bileşikleri. TR200401511T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21965700P 2000-07-21 2000-07-21

Publications (1)

Publication Number Publication Date
TR200401511T4 true TR200401511T4 (tr) 2004-08-23

Family

ID=22820176

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/01511T TR200401511T4 (tr) 2000-07-21 2001-07-16 Nöropatik ağrı ve baş ağrısı nöbetleri ve migren tipi baş ağrısı ile ilişkili ağrının önlenmesi veya tedavi edilmesinde kullanılan karbamat bileşikleri.

Country Status (28)

Country Link
US (4) US20020107283A1 (tr)
EP (1) EP1305082B1 (tr)
JP (1) JP5271473B2 (tr)
KR (1) KR100792814B1 (tr)
CN (1) CN1250213C (tr)
AT (1) ATE267629T1 (tr)
AU (2) AU2001273493B2 (tr)
BG (1) BG107529A (tr)
BR (1) BR0112713A (tr)
CA (1) CA2416819C (tr)
CZ (1) CZ2003445A3 (tr)
DE (1) DE60103546T2 (tr)
DK (1) DK1305082T3 (tr)
EA (1) EA005648B1 (tr)
ES (1) ES2221651T3 (tr)
HU (1) HUP0302940A3 (tr)
IL (2) IL154052A0 (tr)
MX (1) MXPA03000619A (tr)
MY (1) MY127317A (tr)
NO (1) NO330055B1 (tr)
NZ (1) NZ523851A (tr)
PL (1) PL365701A1 (tr)
PT (1) PT1305082E (tr)
SK (1) SK1962003A3 (tr)
TR (1) TR200401511T4 (tr)
UA (1) UA74195C2 (tr)
WO (1) WO2002007822A2 (tr)
ZA (1) ZA200301403B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ527994A (en) 2001-02-27 2005-11-25 Ortho Mcneil Pharm Inc Carbamate compounds for use in the treatment of pain
US20030083372A1 (en) 2001-07-16 2003-05-01 Codd Ellen C. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
CN101669933A (zh) * 2001-07-16 2010-03-17 奥索-麦克尼尔药品公司 用于预防或治疗神经性疼痛和丛集性头痛及偏头痛性疼痛的氨基甲酸酯化合物
US20040087642A1 (en) * 2002-10-24 2004-05-06 Zeldis Jerome B. Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
US7323443B2 (en) * 2002-12-12 2008-01-29 Agennix Inc. Lactoferrin in the reduction of pain
US7183381B2 (en) * 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof
CA2595599A1 (en) * 2005-01-20 2006-07-27 Janssen Pharmaceutica N.V. Methods for qt interval control
EA015833B1 (ru) 2006-03-30 2011-12-30 Глаксосмитклайн Байолоджикалс С.А. Иммуногенная композиция
US20080194860A1 (en) * 2006-10-10 2008-08-14 Transform Pharmaceuticals, Inc. Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US20150057351A1 (en) * 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
HU191549B (en) * 1984-04-11 1987-03-30 Richter Gedeon Vegyeszet Process for producing 1-/6-/2 comma above-substituted-5 comma above, 6 comma above, 7 comma above, 8 comma above-tetrahydro-4 comma above-oxo-quinazolino//-3,4-dihydro-6,7-disubstituted-isoquinoline derivatives
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines
GB9518027D0 (en) * 1995-09-05 1995-11-08 Wellcome Found Pharmacologically active compound
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
KR20010013435A (ko) * 1997-06-05 2001-02-26 고든 라이트 5-나프탈렌-1-일-1,3-디옥산 유도체, 제조 및 치료에의 이용
WO2002067927A1 (en) * 2001-02-27 2002-09-06 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating psychotic disorders
HUP0303243A3 (en) * 2001-02-27 2012-07-30 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing and treating bipolar disorder
PL364679A1 (en) * 2001-02-27 2004-12-13 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating movement disorders

Also Published As

Publication number Publication date
BR0112713A (pt) 2003-07-22
AU2001273493B2 (en) 2005-08-11
EA200300042A1 (ru) 2003-06-26
NO20030299L (no) 2003-03-12
NO330055B1 (no) 2011-02-14
WO2002007822A2 (en) 2002-01-31
WO2002007822A3 (en) 2002-05-30
CZ2003445A3 (cs) 2004-08-18
PT1305082E (pt) 2004-09-30
JP5271473B2 (ja) 2013-08-21
PL365701A1 (en) 2005-01-10
NO20030299D0 (no) 2003-01-20
BG107529A (bg) 2003-09-30
ES2221651T3 (es) 2005-01-01
HUP0302940A2 (hu) 2003-12-29
NZ523851A (en) 2004-09-24
EA005648B1 (ru) 2005-04-28
KR20030022300A (ko) 2003-03-15
CA2416819C (en) 2011-03-22
US20040266866A1 (en) 2004-12-30
EP1305082B1 (en) 2004-05-26
CA2416819A1 (en) 2002-01-31
HUP0302940A3 (en) 2012-02-28
AU7349301A (en) 2002-02-05
IL154052A (en) 2008-07-08
EP1305082A2 (en) 2003-05-02
CN1458853A (zh) 2003-11-26
KR100792814B1 (ko) 2008-01-14
JP2004504362A (ja) 2004-02-12
ZA200301403B (en) 2004-06-15
MY127317A (en) 2006-11-30
SK1962003A3 (en) 2004-08-03
US20020107283A1 (en) 2002-08-08
DE60103546D1 (de) 2004-07-01
ATE267629T1 (de) 2004-06-15
DE60103546T2 (de) 2005-06-09
CN1250213C (zh) 2006-04-12
IL154052A0 (en) 2003-07-31
US20060183795A1 (en) 2006-08-17
UA74195C2 (uk) 2005-11-15
US20090281179A1 (en) 2009-11-12
MXPA03000619A (es) 2004-07-30
DK1305082T3 (da) 2004-09-13

Similar Documents

Publication Publication Date Title
YU67703A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
TR200401511T4 (tr) Nöropatik ağrı ve baş ağrısı nöbetleri ve migren tipi baş ağrısı ile ilişkili ağrının önlenmesi veya tedavi edilmesinde kullanılan karbamat bileşikleri.
YU68003A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju i lečenju bipolarnih poremećaja
NO20033802D0 (no) Karbamatforbindelser for anvendelse ved forebygging eller behandling av bipolar forstyrrelse
RS67603A (en) Carbamate compounds for use in the treatment of pain
DK1399144T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser
RS67503A (en) Carbamate compounds for use in preventing of treating psychotic disorders
CY1109429T1 (el) Καρβαμιδικες ενωσεις για χρηση στην προληψη ή τη θεραπεια του πονου λογω νευροπαθειας
CY1106038T1 (el) Καρβαμικες ενωσεις για χρηση στην προληψη ή την αγωγη του νeυpοπαθους πονου και του πονου που συνδεεται με την ισταμινογενη κεφαλαλγια και την ημικρανια
MY136347A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain